Despite a multi-billion-dollar takeover bid from Novo Holdings, contract manufacturer Catalent appears to be continuing with the internal restructuring scheme it unveiled last year. For more than ...
Danaher (DHR) closed the latest trading day at $254.39, indicating a -0.7% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 1.02%.
Danaher (DHR) closed the most recent trading day at $251.47, moving +0.83% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.63% for the day.
Thousands of Houston ISD students have left the district since the Texas Education Agency's takeover, on top of an already declining enrollment, amounting to a 12 percent drop in students over the ...
While Catalent’s acquisition is definitely about making drugs, it’s also very much about making money. Novo Holdings’ acquisition of Catalent, in retrospect, was entirely logical (1). We are tempted ...
Whales with a lot of money to spend have taken a noticeably bearish stance on Danaher. Looking at options history for Danaher DHR we detected 8 trades. If we consider the specifics of each trade ...
WASHINGTON, March 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, April 23, 2024 ...
Drug maker Catalent is cutting 130 jobs in Bloomington. The company said in an emailed statement the cuts are part of the company’s efforts to increase efficiencies and lower costs, but did not ...
Drug maker Catalent is cutting 130 jobs in Bloomington. The company said in an emailed statement the cuts are part of the company’s efforts to increase efficiencies and lower costs, but did not ...